Risankizumab Induction Therapy for Patients With Crohn ' s Disease Risankizumab Induction Therapy for Patients With Crohn ' s Disease

This study evaluated the effectiveness and safety of risankizumab induction therapy in a cohort of patients with Crohn ' s disease refractory to other biologic therapies.Alimentary Pharmacology & Therapeutics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news